Arcutis Biotherapeutics Inc (ARQT): Next-Year EPS Estimate 436.89%
As of 2026-06-11, Arcutis Biotherapeutics Inc (ARQT) has a next-year EPS growth estimate of 436.89%.
On 2026-05-17, analyst consensus for ARQT's next-year EPS growth shifted from 437.74% to 436.89% — a negative change of 0.85 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 253.13%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 436.89%
- EPS growth this year
- 253.13%
- EPS next quarter (est)
- $0.04
- Last price
- $24.59
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 436.89% | 253.13% | $0.04 | $24.59 |
| 2026-06-10 | 436.89% | 253.13% | $0.04 | $23.23 |
| 2026-06-09 | 436.89% | 253.13% | $0.04 | $22.79 |
| 2026-06-08 | 436.89% | 253.13% | $0.04 | $21.54 |
| 2026-06-07 | 436.89% | 253.13% | $0.04 | $21.23 |
| 2026-06-04 | 436.89% | 253.13% | $0.04 | $21.95 |
| 2026-06-03 | 436.89% | 253.13% | $0.04 | $21.35 |
| 2026-06-02 | 436.89% | 253.13% | $0.04 | $20.79 |
| 2026-06-01 | 436.89% | 253.13% | $0.04 | $21.47 |
| 2026-05-31 | 436.89% | 253.13% | $0.04 | $21.46 |
| 2026-05-28 | 436.89% | 253.13% | $0.04 | $21.44 |
| 2026-05-27 | 436.89% | 253.13% | $0.04 | $21.15 |
| 2026-05-26 | 436.89% | 253.13% | $0.04 | $21.11 |
| 2026-05-25 | 436.89% | 253.13% | $0.04 | $20.86 |
| 2026-05-24 | 436.89% | 253.13% | $0.04 | $20.86 |
| 2026-05-21 | 436.89% | 253.13% | $0.04 | $21.01 |
| 2026-05-20 | 436.89% | 253.13% | $0.04 | $20.47 |
| 2026-05-19 | 436.89% | 253.13% | $0.04 | $19.50 |
| 2026-05-18 | 436.89% | 253.13% | $0.04 | $20.03 |
| 2026-05-17 | 436.89% | 253.13% | $0.04 | $21.32 |
| 2026-05-14 | 437.74% | 252.88% | $0.04 | $21.57 |
| 2026-05-13 | 437.74% | 252.88% | $0.04 | $21.88 |
| 2026-05-12 | 437.74% | 252.88% | $0.04 | $20.69 |
| 2026-05-11 | 437.74% | 252.88% | $0.04 | $21.24 |
| 2026-05-10 | 437.74% | 252.88% | $0.04 | $21.17 |
| 2026-05-07 | 437.74% | 252.88% | $0.04 | $20.66 |
| 2026-05-06 | 328.78% | 304.66% | -$0.06 | $24.17 |
| 2026-05-05 | 328.78% | 304.66% | -$0.06 | $23.42 |
| 2026-05-04 | 328.78% | 304.66% | -$0.06 | $23.49 |
| 2026-05-03 | 328.78% | 304.66% | -$0.06 | $23.35 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Arcutis Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Arcutis Biotherapeutics Inc (ARQT) has a next-year EPS growth estimate of 436.89%, based on analyst consensus.
When was the latest EPS estimate revision for ARQT?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 437.74% to 436.89%.
What sector and industry does Arcutis Biotherapeutics Inc belong to?▾
Arcutis Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ARQT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Arcutis Biotherapeutics Inc (ARQT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports